gallic acid has been researched along with pirarubicin in 1 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 1 (100.00) | 2.80 |
Authors | Studies |
---|---|
Aye, KT; Kothan, S; Pan, J; Supawat, B; Tima, S; Tungjai, M; Udomtanakunchai, C; Wattanapongpitak, S | 1 |
1 other study(ies) available for gallic acid and pirarubicin
Article | Year |
---|---|
Gallic acid enhances pirarubicin‑induced anticancer in living K562 and K562/Dox leukemia cancer cells through cellular energetic state impairment and P‑glycoprotein inhibition.
Topics: Antineoplastic Agents; ATP Binding Cassette Transporter, Subfamily B, Member 1; Cell Survival; Doxorubicin; Drug Resistance, Neoplasm; Drug Synergism; Gallic Acid; Humans; K562 Cells; Leukemia | 2021 |